Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies

Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies

Introduction: COVID-19 manifests with symptoms ranging from mild to severe, including respiratory and cardiovascular complications. Severe cases are often marked by a cytokine storm, causing pulmonary damage and multi-organ dysfunction. Current treatments lack a specific antiviral, though several p...

Full description

Bibliographic Details
Main Authors: Paulina Klaudia Kwaśniewska, Patryk Graczyk, Anna Wilewska, Kinga Borowiec, Agnieszka Borowiec, Julia Biernikiewicz, Konstanty Alabrudziński, Milena Biernikiewicz, Bartosz Pomirski, Agata Pomirska
Format: Article
Language:English
Published: Kazimierz Wielki University 2024-12-01
Series:Journal of Education, Health and Sport
Subjects:
COVID-19
baricitinib
JAK inhibitors
immunomodulatory therapy
SARS-CoV
Online Access:https://apcz.umk.pl/JEHS/article/view/56441

Internet

https://apcz.umk.pl/JEHS/article/view/56441

Similar Items